Published: Thu, October 11, 2018
Medical | By

FDA OKs HPV Vaccine for Adults Up to Age 45

FDA OKs HPV Vaccine for Adults Up to Age 45

On Friday, the Food and Drug Administration announced that Gardasil 9, the preventative HPV vaccine, is now approved and available for older adults women and men ages 27 to 45 (previously it was only offered to those ages 26 and younger).

The approval was constructed from a study among women ages 27-45, showing that the previous version of the vaccine had great impact preventing the persistent infection of HPV, genital warts, vaginal and vulvar precancers, cervical cancer, and cervical precancers related to the types of virus covered by the vaccine.

"Today's approval represents an important opportunity to help prevent HPV-related diseases and cancers in a broader age range", Peter Marks, MD, PhD, director of the FDA's Center for Biologics Evaluation and Research", said in a press release. While that iteration is no longer distributed in the United States, in 2014, the FDA approved Gardasil 9, which not only covers the original four types of HPV but also an additional five strains and was approved for people ages 9 through 26.

HPV strains cause the most common sexually transmitted infections in the world and are responsible for almost all cases of cervical cancer, according to the Academy of Family Physicians.

The study involved about 3,200 women, aged 27 to 45.

The most commonly reported adverse reactions are injection site pain, swelling, redness and headaches.

The works I contrast to the human papillomavirus, HPV that can also bring along cancers of the vulva, and genital warts, penis, anus, and parts of the throat.

But even someone who has already been exposed to a few strains — but not to all nine in the vaccine — can still gain protection against the strains they have not encountered.

"Although most studies have shown a general link between HPV and HIV co-infection, our findings illustrate the strong relationship between individual HPV types and HIV infection", said Brandon Brown, an HIV researcher and associate professor in the UCR School of Medicine and the lead author of the study.

"To lower your risk of HPV, you must get vaccinated", Dr. Ross says.

A wart typically will appear three weeks to eight months after an infection, and most people who contract HPV don't know they're infected and don't develop symptoms. It is estimated 14 million people will get HPV each year. And while the HPV vaccine will not cause any harm, D'Souza said, medical organizations won't make any official recommendations until they have ample data showing the benefits of the vaccine for the entire age group.

Merck said the list price for Gardasil 9 is $205 per dose. According to a report from the The New York Times, the FDA is now looking into making a recommendation for the use of the vaccine in older people for scenarios like these.

Like this: